SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-029035
Filing Date
2018-05-09
Accepted
2018-05-09 19:58:41
Documents
2
Period of Report
2018-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4297
2 EX-24 DOCUMENT attachment1.htm EX-24 3392
  Complete submission text file 0001209191-18-029035.txt   9222
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address
Spellman Mary (Reporting) CIK: 0001740108 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38356 | Film No.: 18820143